NeuroEndocrine Cancer Australia, in collaboration with the eResearch department at Melbourne University, have developed a world class Neuroendocrine Tumour (NET) registry and mobile app.
The Planet App allows patients to enter information relevant to their ongoing NET care provided by their health professionals and will assist in accurately recording their personal stats, housing all relevant information in one location.
This data will then be safely and securely uploaded by the relevant hospital to assist in the collection of vital data and future care and treatment for all NET patients.
Quality of Life survey questions are asked to collect feedback about your general well-being and happiness or unhappiness about life.
The Bristol Stool Scale is a diagnostic medical tool designed to classify the form of human faeces into seven categories.
Recording your weight weekly will help you and your medical team to identify any fluctuations quickly.
Developed by the Eastern Cooperative Oncology Group, ECOG performance measures how NETs impacts a patient’s daily living abilities.
Safe and secure (patient information remains de-identified).
Endorsed by Melbourne University eResearch department.
Streamlining the collection of accurate patient data.
Assisting in the collection of vital data for the future care and treatment of NET patients.
To ensure the safety and security of this app, a unique verification code will be required to access the app. ONLY your clinician will be able to provide you with this code AFTER you have consented to being added to the PLANET registry.
Download the PLANET app using the instructions below and ask your clinician for your unique authentication code at your next appointment so you can start entering your vitals today.
To change your notification frequency, go to “Settings”, click on “Reminders”, enable notifications, and set the time and frequency you want to be sent an alert.
From time to time you may receive a message from your clinician. It is the hope of this project, to be able to easily identify patients for clinical trials so that we can improve NET research into the future.
| Treatment | App Use Frequency |
| SSA | Monthly |
| PRRT | Monthly |
| Chemo–Carbo/Etop | 3 weekly |
| CAPTEM | 4 weekly |
| Everolimus | Initially 1-2 weeks, then 4 – 6 weekly |
| Sunitinib | Initially 1-2 weeks, then 4 – 6 weekly |
| Telotristat | Variable depending on other treatment |
